Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT05375383
Registration number
NCT05375383
Ethics application status
Date submitted
11/05/2022
Date registered
16/05/2022
Titles & IDs
Public title
Microbial Colonization of Oral Probiotics
Query!
Scientific title
Assessment of Colonisation of Probiotic Bacterium Streptococcus Salivarius in the Oral Cavity
Query!
Secondary ID [1]
0
0
BLTCT2022/3
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Microbial Colonization
0
0
Query!
Condition category
Condition code
Infection
0
0
0
0
Query!
Studies of infection and infectious agents
Query!
Infection
0
0
0
0
Query!
Other infectious diseases
Query!
Infection
0
0
0
0
Query!
Sexually transmitted infections
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Other - Streptococcus salivarius K12 lozenge
Treatment: Other - Probiotic S. salivarius K12 lozenges containing prebiotic A
Treatment: Other - Probiotic S. salivarius K12 lozenges containing prebiotic B
Treatment: Other - Probiotic S. salivarius K12 lozenges containing prebiotics A and B
Treatment: Other - Probiotic S. salivarius K12 powder
Treatment: Other - Probiotic S. salivarius K12 powder containing prebiotic A
Treatment: Other - Probiotic S. salivarius K12 powder containing prebiotic B
Treatment: Other - Probiotic S. salivarius K12 powder containing prebiotics A and B
Treatment: Other - Probiotic S. salivarius M18 lozenges
Treatment: Other - Probiotic S. salivarius M18 lozenges containing prebiotic A
Treatment: Other - Probiotic S. salivarius M18 lozenges containing prebiotic B
Treatment: Other - Probiotic S. salivarius M18 + lozenges containing prebiotic A and B
Active comparator: Streptococcus salivarius K12 lozenge - Streptococcus salivarius K12 lozenge
Active comparator: Probiotic S. salivarius K12 lozenges containing prebiotic A - Streptococcus salivarius K12 lozenge with prebiotic
Active comparator: Probiotic S. salivarius K12 lozenges containing prebiotic B - Streptococcus salivarius K12 lozenge with prebiotic
Active comparator: Probiotic S. salivarius K12 lozenges containing prebiotic A and B - Streptococcus salivarius K12
Active comparator: Probiotic S. salivarius K12 powder - Streptococcus salivarius K12 powder
Active comparator: Probiotic S. salivarius K12 powder containing prebiotic A - Streptococcus salivarius K12 powder with prebiotic
Active comparator: Probiotic S. salivarius K12 powder containing prebiotic B - Streptococcus salivarius K12 powder with prebiotic
Active comparator: Probiotic S. salivarius K12 powder containing prebiotic A and B - Streptococcus salivarius K12 powder with prebiotic
Active comparator: Probiotic S. salivarius M18 lozenges - Streptococcus salivarius M18 lozenge
Active comparator: Probiotic S. salivarius M18 lozenges containing prebiotic A - Streptococcus salivarius M18 lozenge with prebiotic
Active comparator: Probiotic S. salivarius M18 lozenges der containing prebiotic B - Streptococcus salivarius M18 lozenge with prebiotic
Active comparator: Probiotic S. salivarius M18 + lozenges containing prebiotic A and B - Streptococcus salivarius M18 lozenge with prebiotic
Treatment: Other: Streptococcus salivarius K12 lozenge
In this study, a lozenge will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Treatment: Other: Probiotic S. salivarius K12 lozenges containing prebiotic A
In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Treatment: Other: Probiotic S. salivarius K12 lozenges containing prebiotic B
In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Treatment: Other: Probiotic S. salivarius K12 lozenges containing prebiotics A and B
In this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Treatment: Other: Probiotic S. salivarius K12 powder
In this study, a powder will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
Treatment: Other: Probiotic S. salivarius K12 powder containing prebiotic A
In this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
Treatment: Other: Probiotic S. salivarius K12 powder containing prebiotic B
In this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
Treatment: Other: Probiotic S. salivarius K12 powder containing prebiotics A and B
In this study, a powder containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
Treatment: Other: Probiotic S. salivarius M18 lozenges
In this study, a lozenge containing will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Treatment: Other: Probiotic S. salivarius M18 lozenges containing prebiotic A
In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Treatment: Other: Probiotic S. salivarius M18 lozenges containing prebiotic B
In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Treatment: Other: Probiotic S. salivarius M18 + lozenges containing prebiotic A and B
In this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Query!
Intervention code [1]
0
0
Treatment: Other
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Change in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius K12 lozenges
Query!
Assessment method [1]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [1]
0
0
1 hour
Query!
Primary outcome [2]
0
0
Change in microbial colonization from baseline (Day 0) to 8 hours or S. salivarius K12 lozenges
Query!
Assessment method [2]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to eight hours after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [2]
0
0
8 hour
Query!
Primary outcome [3]
0
0
Change in microbial colonization from baseline (Day 0) to 24 hours or S. salivarius K12 lozenges
Query!
Assessment method [3]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 24 hours after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [3]
0
0
24 hour
Query!
Primary outcome [4]
0
0
Change in microbial colonization from baseline (Day 0) to 48 hours or S. salivarius K12 lozenges
Query!
Assessment method [4]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 48hours after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [4]
0
0
48 hour
Query!
Primary outcome [5]
0
0
in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius K12 powder format
Query!
Assessment method [5]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [5]
0
0
1 hour
Query!
Primary outcome [6]
0
0
in microbial colonization from baseline (Day 0) to 8 hour for S. salivarius K12 powder format
Query!
Assessment method [6]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 8 hours after later across two different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [6]
0
0
8 hours
Query!
Primary outcome [7]
0
0
in microbial colonization from baseline (Day 0) to 24 hours for S. salivarius K12 powder format
Query!
Assessment method [7]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 24 hours after later across two different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [7]
0
0
24 hours
Query!
Primary outcome [8]
0
0
in microbial colonization from baseline (Day 0) to 48 hours for S. salivarius K12 powder format
Query!
Assessment method [8]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius K12 with or without prebiotics from a powder format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 48 hours after later across two different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [8]
0
0
48 hours
Query!
Primary outcome [9]
0
0
Change in microbial colonization from baseline (Day 0) to 1 hour for S. salivarius M18 lozenges
Query!
Assessment method [9]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [9]
0
0
1 hour
Query!
Primary outcome [10]
0
0
Change in microbial colonization from baseline (Day 0) to 8 hours for S. salivarius M18 lozenges
Query!
Assessment method [10]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 8 hour after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [10]
0
0
8 hour
Query!
Primary outcome [11]
0
0
Change in microbial colonization from baseline (Day 0) to 24 hours for S. salivarius M18 lozenges
Query!
Assessment method [11]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 24 hour after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [11]
0
0
24 hour
Query!
Primary outcome [12]
0
0
Change in microbial colonization from baseline (Day 0) to 48 hours for S. salivarius M18 lozenges
Query!
Assessment method [12]
0
0
Study will determine the change in microbial colonization efficacy of Streptococcus salivarius M18 with or without prebiotics from a lozenge format. The statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to 48 hour after later across different formulations with the level of significance of p=0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).
Query!
Timepoint [12]
0
0
48 hour
Query!
Eligibility
Key inclusion criteria
Inclusion criteria:
1. Male or Female 18y - 80y age
2. In general good health 18 - 80 years of age.
3. Practice good oral hygiene.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
80
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Exclusion criteria:
1. Have a history of autoimmune disease or are immunocompromised.
2. Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
3. History of allergy (e.g. dairy).
Query!
Study design
Purpose of the study
Other
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
NA
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
UNKNOWN
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
15/06/2022
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
15/09/2022
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment outside Australia
Country [1]
0
0
New Zealand
Query!
State/province [1]
0
0
Otago
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
BLIS Technologies Limited
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The aim of this study is to evaluate the colonization efficacy of probiotic lozenges and powders containing specific prebiotics in healthy adults
Query!
Trial website
https://clinicaltrials.gov/study/NCT05375383
Query!
Trial related presentations / publications
Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol. 2007 Feb;73(4):1107-13. doi: 10.1128/AEM.02265-06. Epub 2006 Dec 28. Burton JP, Chilcott CN, Wescombe PA, Tagg JR. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12. Probiotics Antimicrob Proteins. 2010 Oct;2(3):135-44. doi: 10.1007/s12602-010-9045-4. Gregori G, Righi O, Risso P, Boiardi G, Demuru G, Ferzetti A, Galli A, Ghisoni M, Lenzini S, Marenghi C, Mura C, Sacchetti R, Suzzani L. Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study. Ther Clin Risk Manag. 2016 Jan 19;12:87-92. doi: 10.2147/TCRM.S96134. eCollection 2016. Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther. 2013 Mar;13(3):339-43. doi: 10.1517/14712598.2013.758711. Epub 2013 Jan 4. Di Pierro F, Colombo M, Zanvit A, Rottoli AS. Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation. Drug Healthc Patient Saf. 2016 Nov 21;8:77-81. doi: 10.2147/DHPS.S117214. eCollection 2016. Di Pierro F, Colombo M, Giuliani MG, Danza ML, Basile I, Bollani T, Conti AM, Zanvit A, Rottoli AS. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children. Eur Rev Med Pharmacol Sci. 2016 Nov;20(21):4601-4606. Di Pierro F, Zanvit A, Nobili P, Risso P, Fornaini C. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study. Clin Cosmet Investig Dent. 2015 Oct 3;7:107-13. doi: 10.2147/CCIDE.S93066. eCollection 2015. Bardellini E, Amadori F, Gobbi E, Ferri A, Conti G, Majorana A. Does Streptococcus Salivarius Strain M18 Assumption Make Black Stains Disappear in Children? Oral Health Prev Dent. 2020 Apr 3;18(2):161-164. doi: 10.3290/j.ohpd.a43359.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
John D Hale, PhD
Query!
Address
0
0
Blis Technologies Ltd
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
John D Hale, PhD
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
+6434740988
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
Data and information included in the Protocol and Clinical Study Report will be shared to other researchers and/or in publications in due course.
Supporting document/s available: Study protocol, Clinical study report (CSR)
Query!
When will data be available (start and end dates)?
Study report 3 months after the completion of the study.
Query!
Available to whom?
Summary study report will be shared by Principal investigator upon request if not published in public literature.
Query!
Available for what types of analyses?
Query!
How or where can data be obtained?
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT05375383